Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23769700 | 0.92 | KLKB1 (0.86) | KLKB1RIPK1 | |
| SCHEMBL23769664 | 0.92 | KLKB1 (1.00) | KLKB1RIPK1 | |
| SCHEMBL23769706 | 0.86 | KLKB1 (0.85) | KLKB1 | |
| SCHEMBL23769703 | 0.84 | KLKB1 (0.75) | KLKB1RIPK1 | |
| SCHEMBL23769437 | 0.84 | KLKB1 (1.00) | KLKB1 | |
| SCHEMBL23769567 | 0.83 | KLKB1 (1.00) | KLKB1 | |
| SCHEMBL23769573 | 0.83 | KLKB1 (0.68) | KLKB1 | |
| SCHEMBL23769436 | 0.80 | KLKB1 (0.81) | KLKB1 | |
| SCHEMBL23769555 | 0.80 | KLKB1 (0.70) | KLKB1 | |
| SCHEMBL23754301 | 0.79 | KLKB1 (0.53) | KLKB1RIPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210292301-A1 | HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2021-09-23 | — | — | US | disclosed |
| WO-2021160718-A1 | HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2021-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210292301-A1 | HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS | KLKB1, KLK5, KLK1 | KLKB1 1/4885RIPK1 2782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.